Dynavax Technologies | 판매 및 관리 비용



Selling And Administration Expenses 변화 날짜
AbbVie USD 3.25B 40M 2025-06
Adma Biologics USD 24.59M 5.01M 2024-12
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 5.01B 1.42B 2025-06
Biogen USD 583.8M 11.3M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Dynavax Technologies USD 106.33M 64.74M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Merck USD 2.63B 104M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Novartis USD 3.44B 384M 2025-06
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
TG Therapeutics USD 12.04M 38.29M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06


Dynavax Technologies 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Aug 2025.